vitiligo
frequent
found
associ
autoimmun
diseas
autoantibodi
includ
cytotox
antibodi
melanocyt
increas
incid
autosom
domin
pattern
inherit
famili
suggest
genet
factor
final
abnorm
cell
subset
especi
invert
cell
ratio
report
human
immunodefici
viru
hiv
infect
helper
cell
cell
caus
immunodysfunct
final
immunodefici
sever
form
aid
acquir
immunodefici
syndrom
earli
hiv
infect
associ
immun
hyperstimul
lymphadenopathi
polyclon
b
cell
activ
hypergammaglobulinemia
activ
suppressor
cell
ia
aid
patient
loss
langerhan
cell
diminish
antigen
respons
interleukin
gamma
interferon
product
virusspecif
cytotox
viral
infect
especi
herp
simplex
activ
hivinfect
cell
cours
care
dermatolog
problem
hiv
posit
patient
struck
coincid
see
five
patient
short
period
time
develop
vitiligo
evolv
aidsrel
complex
arc
aid
four
report
fifth
lost
followup
addit
aid
patient
gave
histori
develop
vitiligo
hepat
concurr
probabl
long
get
hiv
infect
vitiligo
previous
report
associ
viral
infect
hiv
coincid
suggest
virus
may
inde
serv
trigger
factor
autoimmun
diseas
vitiligo
patient
attend
clinic
immunolog
dermatolog
outpati
clinic
md
anderson
hospit
univers
texa
system
cancer
center
follow
patient
arc
aid
half
symptomat
cutan
complic
preced
year
patient
test
hiv
enzymelink
immunosorb
assay
elisa
follow
western
blot
reth
child
develop
symptom
aidsrel
ceiv
experiment
drug
sign
inform
consent
protocol
approv
institut
review
board
male
homosexu
develop
arc
aidsrel
complex
januari
multipl
infect
includ
mump
coxsacki
viru
hepat
syphili
receiv
azimexon
bm
stabl
symptom
decemb
develop
fever
fatigu
night
sweat
time
note
white
patch
scalp
beard
hair
extensor
surfac
arm
back
fig
evalu
show
ratio
anergi
skin
test
markedli
elev
cytomegaloviru
epsteinbarr
viru
titer
tabl
hepat
b
core
antibodi
hiv
test
show
posit
result
ribavirin
begun
mg
three
time
daili
day
daili
week
develop
photosensit
erupt
week
week
repigment
hair
skin
lesion
began
continu
take
ribavirin
show
improv
case
summar
tabl
ii
patient
develop
vitiligo
within
year
hiv
symptom
patient
child
transfusioninduc
arc
develop
acral
vitiligo
fig
time
develop
parotid
fever
diarrhea
weight
loss
hypergammaglobulinemia
patient
develop
area
vitiligo
month
follow
dissemin
herp
zoster
previou
zoster
lesion
inflamm
note
three
week
start
ribavirin
develop
alopecia
areata
repigment
occur
skin
patient
multipl
persist
chronic
viral
infect
includ
herp
simplex
year
recent
episod
herp
zoster
februari
three
depig
x
macul
appear
sud
denli
chest
without
prior
viral
vesicl
inflamm
time
patient
cytomegaloviru
pneumon
retin
receiv
biopsi
depig
macul
show
atroph
epidermi
reduc
melanin
fig
electron
microscopi
reveal
absent
melanocyt
shown
patient
develop
genit
thigh
vitiligo
lesion
contract
hepat
psoriasi
later
develop
vitiligo
becam
gener
arc
unless
incub
period
hiv
exce
year
contract
vitiligo
prior
hiv
conjunct
form
viral
hepat
evid
previou
hepat
hepat
b
well
viral
inclus
biopsi
suggest
nona
nonb
hepat
five
patient
share
serolog
evid
viral
hepat
elev
liver
enzym
associ
vitiligo
incid
vitiligo
gener
popul
estim
although
four
vitiligo
case
among
sever
hundr
hiv
person
higher
expect
rare
see
newonset
vitiligo
found
coincid
see
four
case
within
month
quit
remark
furthermor
prematur
gray
suggest
relat
vitiligo
lerner
nordlund
j
quit
common
arc
patient
progress
aid
thu
hiv
infect
vifiligo
relat
hiv
opportunist
virus
especi
hepat
dysimmun
may
trigger
vitiligo
genet
predispos
host
evid
relationship
immun
system
vitiligo
exist
immunodefici
vitiligo
report
set
mucocutarl
candidiasi
inde
patient
mucocandidiasi
without
vitiligo
may
circul
antimelanocyt
antibodi
partial
albin
vitiligo
associ
fever
pyogen
infect
hypogammaglobulinemia
reduc
langerhan
ceil
report
two
patient
final
vogtkoyanagiharada
syndrom
virallik
ill
asept
mening
hair
loss
uveiti
dysacousia
vitiligo
specif
hla
class
ii
antigen
ldwa
antibodi
cytotox
melanocyt
similar
antibodi
also
found
vitiligo
patient
mechan
autoimmun
case
vitiligo
unknown
suggest
follow
possibl
exist
could
test
experiment
arcassoci
thrombocytopenia
welldocu
exampl
hivassoci
autoimmun
diseas
destruct
platelet
due
antibodi
react
dalton
plateletassoci
protein
crossreact
herp
simplexinfect
cell
similar
antimelanocyt
antibodi
produc
antivir
crossreact
could
explain
vitiligo
report
patient
coincident
developrn
vitiligo
follow
viral
infect
hepat
hiv
herp
zoster
herp
simplex
cytomegaloviru
would
support
previou
hypothesi
virus
trigger
autoimmun
vitiligo
could
second
report
autoimmun
disord
occur
set
human
immunodefici
viru
